Biotechne share price

Author: cqpa

August undefined, 2024

WebHistorical daily share price chart and data for Bio-Techne Corp since 1992 adjusted for ... WebJun 25, 2024 · Bio-Techne's management team will hold a conference call tomorrow, June 26, 2024 at 8:00 am CDT to discuss the Exosome Diagnostics acquisition. Interested parties may listen to the conference call by dialing 800-263-0877 or 646-828-8143 (for international callers) and referencing conference ID: 7186638.

Sumitomo Mitsui Trust Holdings Inc. Has $84.09 Million Stock …

WebConsensus Price Target is the stock price analysts expect to see within a period of 0-18 months. EPS and Revenue estimates are for the next 12 months. Markets data provided … WebApr 14, 2024 · The biotechnology company reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.41 by ($0.03). Bio-Techne had a return on equity of 15.87% and a net margin of 23.38%. sideways russian flag

National Bank of Canada FI Acquires 4,472 Shares of Bio-Techne …

WebThe Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Bio-Techne Corp’s P/E ratio is 45.86. WebApr 10, 2024 · This rating is based on the ratio between the company's share price and the free cash flow per share generated by its activities, based on the past and analysts' estimates for the coming years. The lower the ratio, the better the rating. Yield "Yield" rating is based on the dividend relative to its share price ... WebApr 14, 2024 · The company has a market cap of $13.14 billion, a PE ratio of 51.89, a price-to-earnings-growth ratio of 2.47 and a beta of 1.25. The company has a debt-to-equity … the poe sisters

Sumitomo Mitsui Trust Holdings Inc. Has $84.09 Million Stock …

Bio-Techne To Acquire Exosome Diagnostics, Inc.

WebThe average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. ... Whether you're buying your first share or investing for the long-haul, we have you covered ... WebMarket cap: $11.66 Billion. As of April 2024 Bio-Techne has a market cap of $11.66 Billion . This makes Bio-Techne the world's 1321th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used ... the poerschke law firmWebApr 13, 2024 · MINNEAPOLIS, April 13, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will present its portfolio of products and solutions to advance cancer research and enable cell and gene therapy development and manufacturing at the upcoming annual meeting of the American Association for Cancer Research … the poem the rainbow bridge

"WebApr 6, 2024 · Complete Bio-Techne Corp. stock information by Barron's. View real-time TECH stock price and news, along with industry-best analysis. " - Biotechne share price

Biotechne share price

BioTechne Corp (TECH) Price To Free Cash Flow - Zacks.com

WebApr 14, 2024 · Finally, Royal Bank of Canada dropped their target price on shares of Bio-Techne from $89.00 to $88.00 and set a “sector perform” rating on the stock in a report … WebMay 2, 2024. EPS forecast (this quarter) $0.53. Annual revenue (last year) $1.1B. Annual profit (last year) $271.9M. Net profit margin. 24.60%.

Did you know?

WebBio-Techne Corporation's (NASDAQ:TECH) recent US$602m market cap decline means a loss of US$6.2k for insiders who bought this year. Simply Wall St. Aug-30-22 07:00AM. … WebAug 5, 2024 · Delivered adjusted earnings per share (EPS) of $1.87 versus $1.00 one year ago. Full year GAAP EPS was $3.47 vs $5.82 one year ago. Full year adjusted EPS was $6.75 vs $4.55 in the prior year. ... the impact of the growing number of producers of biotechnology research products and related price competition, general economic …

WebApr 10, 2024 · A high-level overview of Bio-Techne Corporation (TECH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … WebView the latest Bio-Techne Corp. (TECH) stock price, news, historical charts, analyst ratings and financial information from WSJ.

WebMar 31, 2024 · Currently, BIO-TECHNE Corp’s price-earnings ratio is 46.2. BIO-TECHNE Corp’s trailing 12-month revenue is $1.1 billion with a 23.4% profit margin. Year-over-year quarterly sales growth most recently was 0.9%. Analysts expect adjusted earnings to reach $2.013 per share for the current fiscal year. BIO-TECHNE Corp currently has a 0.4% ... WebFind the latest Bio-Techne Corporation (TECH) stock quote, history, news and other vital information to help you with your stock trading and investing. Discover historical prices for TECH stock on Yahoo Finance. View daily, weekly or … Find the latest Bio-Techne Corporation (TECH) stock discussion in Yahoo … Interactive Chart for Bio-Techne Corporation (TECH), analyze all the … See Bio-Techne Corporation (TECH) stock analyst estimates, including earnings … Find out all the key statistics for Bio-Techne Corporation (TECH), including valuation … See the company profile for Bio-Techne Corporation (TECH) including business … Get the detailed quarterly/annual income statement for Bio-Techne Corporation … Find out the direct holders, institutional holders and mutual fund holders for Bio … See Bio-Techne Corporation (TECH) Environment, Social and Governance … Find the latest Bio-Techne Corporation (TECH) stock quote, history, news and …

WebMar 3, 2024 · Over the past six months, its share price has underperformed the S&P500 Index by-8.02%. As of the last closing price of $78.24, shares in BIO-TECHNE were …

WebNov 18, 2024 · As of 18 November 2024, the price of Bio-Techne stock ws standing at $337.84 a share. If a 4-for-1 Bio-Techne stock split is performed today, the post-split … sideways school seriesWebBased in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for ... thepoeplesconvoy.orgWebApr 14, 2024 · The biotechnology company reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.41 by ($0.03). The company had revenue … the poet and the pendulum 意味WebGet the latest BIO-TECHNE Corp (TECH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … sideways screen fixWebApr 10, 2024 · 9 brokerages have issued 1 year target prices for Bio-Techne's shares. Their TECH share price forecasts range from $88.00 to $120.00. On average, they anticipate the company's stock price to reach … the poetaster ben jonsonWebThe latest Bio-Techne Corp Ordinary USD0.01 share price. View recent trades and share price information for Bio-Techne Corp Ordinary USD0.01 the poet and the peasant o henryWeb2 days ago · The firm has a market cap of $12.24 billion, a PE ratio of 48.32, a price-to-earnings-growth ratio of 2.40 and a beta of 1.25. Bio-Techne Co. has a 52-week low of $68.00 and a 52-week high of $108.19. The company has a quick ratio of 3.15, a current ratio of 4.40 and a debt-to-equity ratio of 0.11. the poet and the boy 2017